Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Microbiology Testing Market Research Report Information By Product Type (Consumables, Instruments), By Type of Test (Bacterial, Viral, Fungal), By Application (Gastrointestinal Infections, Respiratory Infections, Urinary Tract Infections, Sexually Transmitted Infection), By End User (Hospital Assisted Laboratory, Independent Laboratory, Academic and Research Institutes), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

ID: MRFR/HC/0226-CR | 166 Pages | Author: Rahul Gotadki| June 2021

Global Microbiology Testing Market Overview

Microbiology Testing Market Size was valued at USD 3.1 billion in 2022 and is projected to grow from USD 3.42 Billion in 2023 to USD 7.54 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.4% during the forecast period (2023 - 2032). Increased cases of infectious diseases, technological advancements, and disease surveillance programs. These are just a few of the market drivers that are driving the Microbiology Testing market.

Microbiology Testing Market Overview

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

In September 2023, LuminUltra, a globally recognized leader in applied molecular diagnostics, announced that it had given commercial access to its latest product, BugCount Guardian. BugCount® Guardian is an advanced version of 2nd Generation ATP® testing. It combines the well-known speed and reliability of the patented test with the added advantage of continuous process monitoring through automated sampling, trending, analysis, and reporting. BugCount® Guardian effortlessly integrates into the client's industrial process, performing the test, providing results, and automatically collecting samples at intervals specified by the user, without the need for human involvement. The results can be accessed on the instrument itself and are also uploaded to a centralized program for analysis and evaluation through network connectivity. Therefore, the procedure of gathering several data points is significantly simplified, finally enabling the prompt identification of abnormalities and changes happening within a system. 

In February 2023, Hardy Diagnostics unveiled the CompactDry TCR. This desiccated culture medium plate is immediately usable and allows for the determination of total aerobic plate counts within 24 hours, specifically for the identification and quantification of microorganisms. This self-diffusing plate, accredited by AOAC PTM (Association of Official Analytical Chemists - Performance Tested Methods), eliminates the requirement for spreading or stamping, making it the most straightforward approach to do plate counts. Once the incubation period is over, you may easily take off the cover, pour 1mL of the sample onto the middle of the plate, and put the lid back on. Hardy Diagnostics provides several workflow solutions, such as the LabRobot Dilugent Shaker and Wizard CompactDry reader, to expedite the serial dilution and plate-counting operations.

Rising rates of infectious diseases, improved diagnostic tools, and proactive disease monitoring initiatives. The market for microbiology testing is being propelled by many factors, some of which are listed above. The government's spending on medical treatment. The expansion of the market is a likely result of the government's increased assistance. Attractive market expansion potential will also be provided by the development and expansion of the healthcare sector, pushed by public and private actors, especially in emerging nations.

The market would gain even more if research initiatives guaranteed high returns on investment. Increases in the number of orthopedic and cardiac procedures, consumer spending, the availability of cutting-edge medical products and devices in hospitals, research and development funding, and consumer awareness of food safety issues all contribute to the market's expansion. Therefore, this factor is expected to boost income in the worldwide Microbiology Testing market.

In November 2022, the National Drug Authority (NDA) opened a state-of-the-art microbiology laboratory at Mulago, at a cost of about $160,000. The laboratory broadens the purview of NDA to include testing the efficacy and safety of non-sterile and sterile products (including vaccinations). As a result, the country will save money it would have spent on testing at foreign labs and have faster turnarounds for new drug applications (NDAs). The NDA is the primary federal agency responsible for regulating pharmaceuticals for both humans and animals.

Microbiology Testing Market Trends

  • Increased illness prevalence, advancements in research and development, and government spending on healthcare infrastructure will boost the market growth

Several newly developed molecular diagnostic methods are being employed more often for early identification and efficient treatment of pathogen-borne disorders. Compared to conventional laboratory procedures, advanced molecular diagnostic techniques provide several technical advantages, including a quicker turnaround time, a high sample throughput, multiplexing of reactions, specificity, higher accuracy, and greater device sensitivity. NGS, real-time PCR, molecular cartridges, and PCR combined with mass spectrometry are a few examples of advanced molecular diagnostic techniques that are increasingly being recognized for their abilities to identify and characterize a variety of pathogens and analyze multiple samples in a single run.

As a result, these goods are now preferred and used more frequently by important end users, including healthcare providers (such as hospitals and microbiological and clinical centers), research labs, and pharmaceutical and biotechnology firms. Better sample usage and the adoption of a clear clinical technique for diagnosing certain diseases have resulted from developing and marketing pathogen-specific reagent/diagnostic kits. Many well-known product manufacturers are concentrating on creating and commercializing cutting-edge molecular diagnostic solutions to detect infectious diseases to keep up with the shifting end-user demands. Thus, this factor is driving the Microbiology Testing market CAGR.

Investments made by the government in the healthcare system. The federal government's increased support will likely accelerate market expansion. Additionally, the development and expansion of the healthcare sector, pushed by public and private actors, particularly in developing nations, will provide attractive market expansion potential. High investment returns, guaranteed by research efforts, would also benefit the market. Additionally, the market growth rate is positively impacted by the rise in orthopedic and cardiac surgeries, rise in personal disposable income, the introduction of technologically advanced products in hospitals, rising investment in the development of cutting-edge medical products and devices, and rise in food safety concerns. Thus, this aspect will accelerate the Microbiology Testing market revenue globally.

Microbiology Testing Market Segment Insights

Microbiology Testing Product Type Insights

The Microbiology Testing Market segmentation, based on product type, includes Consumables and Instruments. The Consumables segment held the majority share in 2022 in the Microbiology Testing Market data. The significant adoption of traditional laboratory instruments among academics and researchers (coupled with expanding industry-academia collaborations for genomic research), technological developments in the fields of molecular methods and proteomics (such as the integration of microfluidics with PCR and nanotechnology with qPCR techniques), and the ongoing trend of laboratory automation among clinical labs are all factors that contribute to this segment's size.

Microbiology Testing Type of test Insights

Based on the type of test, the Microbiology Testing Market segmentation includes Bacterial, Viral, and Fungal. The Bacterial segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The significant market share of this sector is largely attributable to the high incidence of bacteria-caused foodborne illnesses and the strict guidelines for bacterial contamination in food and beverage processing.

Figure 1: Microbiology Testing Market, by type of test, 2022 & 2030 (USD Billion)Microbiology Testing Market, by type of test, 2022 & 2030Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Microbiology Testing Application Insights

Based on application, the Microbiology Testing Market data include Gastrointestinal Infections, Respiratory Infections, Urinary Tract Infections, and Sexually Transmitted Infections. The non-store-based segment dominated the Microbiology Testing market revenue in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Many businesses have moved online in response to COVID-19 to spread their contagion. The market is one of the businesses that made the leap to the internet by providing a constraint. Online stores are increasingly becoming the norm for European shoppers, and upscale retailers have gone online.

Microbiology Testing End-user Insights

Based on End-user, the Microbiology Testing Market data includes Hospital Assisted laboratories, Independent laboratories, and Academic and Research Institutes. The Hospital Assisted Laboratory segment dominated the Microbiology Testing market revenue in 2022 and is projected to be the faster-growing segment during the forecast period 2022-2030. The high frequency of infectious illnesses such as COVID-19, malaria, dengue, gastrointestinal infections, T.B., and HIV, as well as technology developments in microbiology testing automation, are principally responsible for this segment's sizable market share.June 2023: Newly launched BugCount petroleum, developed by LuminUltra, is a fast and easy way to test fuels for microbial contamination, which can pose serious problems in many fields, including aviation, maritime, and petroleum management. In the backdrop of rising demand for passenger and freight transit, rising recreational travel, and broad acceptance of green initiatives like sustainable aviation fuel (SAF), industries like aviation are rapidly increasing their need for effective, fast microbiological testing solutions.In June 2023, Solvay finished building a state-of-the-art microbiology facility at its Lyon, France headquarters. The Group's skills in biodegradability and toxicity testing will be bolstered by the new laboratory in Lyon, France, which will also improve customer service and strengthen the Group's knowledge. Solvay is already actively engaged in tackling the key issues faced by the agrochemical and home and personal care businesses in delivering zero-pollution products as a leading provider of specialized ingredients that increase performance in these markets. With this new facility, the Group will be able to increase its efforts in this direction while also enhancing Solvay's ability to create innovative biodegradable-by-design products.

Microbiology Testing Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. Europe's Microbiology Testing market accounted for USD 1.41 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The microbiological testing market is developing in Europe due to technological developments, increased infectious illnesses and epidemic outbreaks, rising healthcare costs, and expanding private-public support for infectious disease research. The rapidly growing older population, growth in clinical research studies in clinical microbiology, and rising funding, research grants, and investments are key factors influencing the microbiology testing industry. Moreover, the U.K. Microbiology Testing market held the largest market share, and the Germany Microbiology Testing market was the fastest-growing market in the region.

Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: MICROBIOLOGY TESTING MARKET SHARE BY REGION 2022 (%)MICROBIOLOGY TESTING MARKET SHARE BY REGION 2022Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

North America is anticipated to lead the microbiology market. The existence of well-established businesses in sectors like pharmaceutical, biotechnology, and food and beverage is the primary factor of the highest market share. Similarly, current players are engaging in strategic initiatives to increase the capabilities of industrial testing across many applications. For instance, Perfectus Biomed Group, a CRO with offices in the U.S. and U.K., was purchased by NAMSA in October 2022. Through 20 facilities providing lab services across the U.S., Europe, and Asia, this purchase intends to enhance the tailored microbiological services and create a worldwide footprint.

Asia Pacific microbiology market is anticipated have a significant share. Due to improved healthcare facility infrastructure and growing economic growth, which would favor the market, Asia Pacific is predicted to have the industry's quickest growth. For instance, Merck India stated in June 2022 that a Microbiology Application Training Lab (MAT Lab) would be established in Bangalore for academic and commercial objectives. The Lab invites Merck and other pharma and biopharma companies to work together to build up their skills for microbial investigation. Further, the China Microbiology Testing market held the largest market share, and the India Microbiology Testing market was the fastest-growing market in the region.

Microbiology Testing Key Market Players & Competitive Insights

Major industry companies are investing a lot of money in R&D to expand their product offerings, which will spur further market expansion for the Microbiology Testing industry. With significant industry changes, including new product launches, mergers and acquisitions, contractual agreements, higher investments, and collaboration with other organizations, market development is also undertaking various strategic activities to expand its global presence. Microbiology Testing industry competitors must provide affordable products to grow and remain in a market that is becoming increasingly competitive.

Manufacturing locally to cut operational costs is one of the main business methods producers use in the global Microbiology Testing industry to benefit customers and increase the market sector. The Microbiology Testing industry has recently given medicine some of the most important advantages. The Microbiology Testing market major player such as BioMérieux SA (France), Beckman Coulter Inc. (U.S.),  Bio-Rad Laboratories Inc. (U.S.),  Hoffmann-La Roche Ltd (Switzerland), Merck KGaA(Germany),  Thermo Fisher Scientific Inc. (U.S.)  Qiagen (Germany), Shimadzu Corporation (Japan), Agilent Technologies Inc. (U.S.), Bruker (U.S.) Company.

A French international biotechnology firm with its headquarters in Marcy-l'Étoile, near Lyon, is called bioMérieux S.A. Through its presence in 44 nations and its extensive network of distributors, bioMérieux provides services to more than 160 nations. In June 2020, Bio Mérieux introduced BIOFIRE MY COPLASMA, a ground-breaking test for finding mycoplasma in drugs used in biotherapy (antibodies, hormones, cells, gene therapy, etc.), the pharmaceutical industry's most dynamic sector. Within the next several months, Europe and a few nations in the Asia Pacific will begin offering the new BIOFIRE MYCOPLASMA test that is already accessible in the United States.

To predict processes occurring at scales ranging from the molecular and genomics-controlled smallest to the environmental Earth system changes at the largest, EMSL scientists and collaborators conduct fundamental research focusing on biological, biogeochemical, and physical principles. EMSL Analytical, Inc. stated in July 2022 that its Houston facility provides PCR testing for the genera Legionella and Bacteroides. The Polymerase Chain Reaction (PCR) method "amplifies" brief DNA fragments. The Houston Institute is an expert in conducting microbiological tests for molds, bacteria, pollutants found in wastewater, E. coli, total coliforms, food pathogens, etc.

Key Companies in the Microbiology Testing market include

  • BioMérieux SA (France)

  • Beckman Coulter Inc. (U.S.)

  • Bio-Rad Laboratories Inc. (U.S.)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Merck KGaA(Germany)

  • Thermo Fisher Scientific Inc. (U.S.)

  • Qiagen (Germany)

  • Shimadzu Corporation (Japan)

  • Agilent Technologies Inc. (U.S.)

  • Bruker (U.S.)

Microbiology Testing Industry Developments

  • November 2022: Tecta-PDS, a forward-thinking Canadian business that automated water microbiology testing for elements including E. coli and total coliforms, was bought by IDEXX. The purchase aided IDEXX in broadening its selection of water microbiological testing solutions for in-field and lab testing.

  • November 2022: A new microbiology lab has been established by Archer Daniels Midland (ADM) at its ADM Specialty Manufacturing site in Decatur, Illinois. The project increased the location's testing capacity and doubled the size of the microbiological laboratory there.

  • June 2022: Integrated medical device CRO STEMart offers thorough sterility and microbial testing of sterile pyrogen-free goods. STEMart is committed to the clinical development of medical devices and diagnostics. Stewart continues offering a full-service experience to assist manufacturers in accomplishing regulatory goals and reducing compliance risks.

Microbiology Testing Market Segmentation

Microbiology Testing Product Type Outlook (USD billion, 2018-2030)

  • Consumables

  • Instruments

Microbiology Testing Type of Test Outlook (USD billion, 2018-2030)

  • Bacterial

  • Viral

  • Fungal

Microbiology Testing Application Outlook (USD billion, 2018-2030)

  • Gastrointestinal Infections

  • Respiratory Infections

  • Urinary Tract Infections

  • Sexually Transmitted Infection

Microbiology Testing End-User Outlook (USD billion, 2018-2030)

  • Hospital Assisted Laboratory

  • Independent Laboratory

  • Academic and Research Institutes

Microbiology Testing Regional Outlook (USD Billion, 2018-2030)

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

Report Attribute/Metric Details
Market Size 2022 USD 3.1 billion
Market Size 2023 USD 3.42 billion
Market Size 2032 USD 7.54 billion
Compound Annual Growth Rate (CAGR)  10.4% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018 - 2021
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Variety, Form, Distribution Channel and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The U.S, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled BioMérieux SA (France), Beckman Coulter Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.),  Hoffmann-La Roche Ltd (Switzerland), Merck KGaA(Germany),  Thermo Fisher Scientific Inc. (U.S.)  Qiagen (Germany), Shimadzu Corporation (Japan), Agilent Technologies Inc. (U.S.), Bruker (U.S.) Company
Key Market Opportunities Research And Development Rising Grants, Collaborations, And Partnerships
Key Market Dynamics Technological Advancements Rising Cases of Infectious Diseases Surveillance Programs for Disease Control Rising Stringency of Standards

Frequently Asked Questions (FAQ) :

The Microbiology Testing Market size was valued at USD 3.1 Billion in 2022.

The Microbiology Testing Market is projected to grow at a CAGR of 10.4% during the forecast period, 2023-2032.

Europe had the largest share in the Microbiology Testing Market

The key players in the Microbiology Testing market are BioMérieux SA (France), Beckman Coulter Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.),  Hoffmann-La Roche Ltd (Switzerland), Merck KGaA(Germany),  Thermo Fisher Scientific Inc. (U.S.)  Qiagen (Germany), Shimadzu Corporation (Japan), Agilent Technologies Inc. (U.S.), Bruker (U.S.) Company.

The Instruments category dominated the Microbiology Testing market in 2022.

Bacteria had the largest share in the Microbiology Testing Market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.